AMED - Amedisys, Inc.
| Previous Close | 165.37 |
| Open | 166.75 |
| Bid | 0.00 x 1300 |
| Ask | 0.00 x 1000 |
| Day's Range | 164.55 - 167.85 |
| 52 Week Range | 103.76 - 167.85 |
| Volume | 317,180 |
| Avg. Volume | 263,922 |
| Market Cap | 5.4B |
| Beta (3Y Monthly) | 1.49 |
| PE Ratio (TTM) | 43.35 |
| EPS (TTM) | 3.85 |
| Earnings Date | Feb 25, 2020 - Mar 2, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 156.82 |
- Insider Monkey
Did Hedge Funds Drop The Ball On Amedisys Inc (AMED)?
Is Amedisys Inc (NASDAQ:AMED) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting […]
- Zacks
Teladoc Adds to its Services With Tailored Nutrition Plans
Teladoc (TDOC) enhances its service portfolio with the addition of personalized diet programs.
- Investor's Business Daily
Why You Should Keep An Eye On These 5 Leading Health Care Stocks
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
- Simply Wall St.
Was Amedisys, Inc.'s (NASDAQ:AMED) Earnings Growth Better Than The Industry's?
When Amedisys, Inc.'s (NasdaqGS:AMED) announced its latest earnings (30 September 2019), I wanted to understand how...
- Zacks
Amedisys (AMED) Up 24.8% Since Last Earnings Report: Can It Continue?
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GuruFocus.com
Urbem's 'Wonderful Business' Series: Chemed
It is good to be boring in the investment world Continue reading...
- Zacks
Zacks.com featured highlights include: Amedisys, PC Connection, NRG and Target
Zacks.com featured highlights include: Amedisys, PC Connection, NRG and Target
- Zacks
Amedisys (AMED) to Broaden Hospice Base With Asana Purchase
Asana's acquisition to be the third hospice care buyout of Amedisys (AMED) in 2019.
- Zacks
4 Momentum Picks Screened on Driehaus Strategy
Richard Herman Driehaus used the "buy high and sell higher" rule to create an investment approach, which appeals to those having a high level of risk appetite.
- GlobeNewswire
Amedisys to Acquire Asana Hospice
Amedisys, Inc. (AMED), America’s leading independent home health, hospice and personal care company, has signed a definitive agreement to acquire Asana Hospice. Under the terms of the agreement, targeted to close on January 1, 2020, Amedisys will acquire 100 percent of the ownership interests in Asana Hospice. Asana provides hospice care to approximately 540 patients daily in eight locations in Pennsylvania, Ohio, Missouri, Kansas and Texas.
- Zacks
The Zacks Analyst Blog Highlights: Amedisys, DaVita, Tenet and Hanger
The Zacks Analyst Blog Highlights: Amedisys, DaVita, Tenet and Hanger
- Zacks
Top Ranked Momentum Stocks to Buy for November 22nd
Top Ranked Momentum Stocks to Buy for November 22nd
- Zacks
4 Healthcare Stocks to Gain From Stellar Q3 Earnings
Prominent activities in the healthcare sector are pushing the sector ahead this quarter.
- Zacks
Amedisys (AMED) Hits Fresh High: Is There Still Room to Run?
Amedisys (AMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Zacks
Here's Why Momentum Investors Will Love Amedisys (AMED)
Does Amedisys (AMED) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Thomson Reuters StreetEvents
Edited Transcript of AMED earnings conference call or presentation 30-Oct-19 3:00pm GMT
Q3 2019 Amedisys Inc Earnings Call
- Zacks
Amedisys, Six Flags Entertainment, Target, Walmart and Disney highlighted as Zacks Bull and Bear of the Day
Amedisys, Six Flags Entertainment, Target, Walmart and Disney highlighted as Zacks Bull and Bear of the Day
- Zacks
Amedisys Partners With nVoq to Improve Clinician Experience
Amedisys (AMED) aims to enhance clinician workflow by integrating nVoq's technology platform into its home health business.
- Zacks
3 Reasons Growth Investors Will Love Amedisys (AMED)
Amedisys (AMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- GlobeNewswire
Amedisys to Present at the 2019 Jefferies London Healthcare Conference
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2019 Jefferies London Healthcare Conference in London, England on Wednesday, November 20, 2019. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life.
- PR Newswire
nVoq and Amedisys Collaborate to Enhance the Clinician Experience
BOULDER Colo., Nov. 12, 2019 /PRNewswire/ -- nVoq, a leading provider of HIPAA compliant speech recognition solutions for the healthcare industry, is pleased to announce its partnership with Amedisys, Inc. (AMED), America's leading independent home health, hospice and personal care company. The partnership will leverage nVoq's innovative technology platform, which supports both mobile and care center-based clinicians, within Amedisys' home health and hospice footprint spanning 38 US states and over 300 locations. "Amedisys is committed to providing our caregivers with the right tools to offer the best possible care for our patients," said Chris Gerard, Amedisys, Chief Operating Officer.
- GlobeNewswire
Amedisys Expanding Commitment to End-of-Life Care for Veterans
Amedisys Inc. (AMED), a leading independent home health, hospice and personal care company, is taking the opportunity on this Veteran’s Day to expand its commitment to honor America’s dying military veterans with the highest quality end-of-life care. The company, as the nation’s third largest hospice provider, is pledging that all of its 137 hospice care centers nationwide by next year will partner with the “We Honor Veterans” program, a collaboration between the U.S. Department of Veteran Affairs and the National Hospice and Palliative Care Organization. The Company currently has 90 percent of its hospice care centers engaged in the We Honor Veterans program.
- Zacks
5 Stocks That Stand Out on Attractive Interest Coverage Ratio
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.
- Zacks
Is Amedisys (AMED) a Great Growth Stock?
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Amedisys (AMED).
